[1]张颖怡 刘金波 刘欢 赵娜 赵红薇 王宏宇.全身动脉粥样硬化斑块与脑梗死的关系:北京血管病变评价研究结果[J].心血管病学进展,2021,(3):277-284.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.020]
 ZHANG YingyiLIU J inboLIU HuanZHAO NaZHAO HongweiWANG Hongyu.The Relationship Between Systematic Atherosclerotic Plaques and Cerebral Infarction:Results from Beijing Vascular Disease Evaluation Study[J].Advances in Cardiovascular Diseases,2021,(3):277-284.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.020]
点击复制

全身动脉粥样硬化斑块与脑梗死的关系:北京血管病变评价研究结果()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年3期
页码:
277-284
栏目:
出版日期:
2021-03-25

文章信息/Info

Title:
The Relationship Between Systematic Atherosclerotic Plaques and Cerebral Infarction:Results from Beijing Vascular Disease Evaluation Study
作者:
张颖怡1 刘金波 12 刘欢 12 赵娜 12 赵红薇 12 王宏宇 123
(1.北京大学首钢医院血管医学中心,北京 100144;2.北京大学医学部血管健康研究中心,北京 100144;3.分子心血管学教育部重点实验室(北京大学)
Author(s):
ZHANG Yingyi1LIU J inbo12LIU Huan12ZHAO Na12ZHAO Hongwei12WANG Hongyu123
(1.Department of Vascular Medicine,Peking University Shougang Hospital,Beijing 100144,China; 2.Vascular Health Research Center of Peking University Health Science Center,Beijing 100144,China; 3.Key Laboratory of Molecular Cardiovascular Sciences (Peking University),Ministry of Education(),Beijing 100144,China)
关键词:
脑梗死动脉粥样硬化斑块炎症
Keywords:
Cerebral infarctionAtherosclerosisPlaquesInflammation
DOI:
10.16806/j.cnki.issn.1004-3934.2021.03.020
摘要:
目的 探讨全身动脉粥样硬化斑块与脑梗死的关系。方法 本研究纳入411例患者[(66.3±13.4)岁,男性52.9%],均进行全身血管超声检查。使用逻辑回归评估全身动脉粥样硬化斑块累及血管床数目、斑块部位与脑梗死的关系。结果 脑梗死组的3~5个部位斑块检出率和颈动脉合并其他部位斑块检出率高于无脑梗死组,伴随白介素-6和心-踝血管指数明显升高。在未调整的模型中,3~5个部位粥样硬化斑块组、颈动脉合并其他部位粥样硬化斑块组发生脑梗死风险分别是无斑块组的2.595倍(95% CI 1 .338~5.031,P<0.05)和2.551倍(95% CI 1.317~4.942,P<0.01)。调整了性别和年龄后,斑块累及血管床数目和斑块部位与脑梗死的关系不显著。结论 在未调整的模型中,与无斑块组相比,3~5个部位血管床粥样硬化斑块组和颈动脉合并其他部位粥样硬化斑块组发生脑梗死风险更高。
Abstract:
Objective We aimed to clarify the relationship between systemic atherosclero tic plaques and cerebral infarction. Methods The study included a total of 41 1 patients[(66.6±13.4) years of age,52.9% of men] into the study. All the subjects underwent a systemic vascular ultrasound examination . The relationship between the number of vascular beds affected ,the plaque site and cerebral infarction was assessed using logical regression . Results The detection rate of plaques in 3 ~5 sites and plaques in the carotid artery with other arteries were higher in the cerebral infarction group than that in non- cerebral infarction group,with a significant increase in the level of interleukin-6 and cardio-ankle vascular index. In the unadjusted model,the risk of stroke was 2.595 times(95% CI 1.338~5.031,P<0.05) and 2.551 times(95% CI 1.317~4.942,P<0.01) higher in the atherosclerotic plaque group at 3 ~5 sites and in the carotid artery with other atherosclerotic plaque sites than that in the non-atherosclerotic plaque group. After Adjusted for sex and age,this relationship was not significant. Conclusion In unadjusted models,the risk of cerebral infarction was higher in atherosclerotic plaque group of 3 ~5 sites and carotid artery with other arteries than that in non-atherosclerotic plaque group.

参考文献/References:

[1] Hoshino T,Sissani L,Labreuche J,et al. Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease[J]. JAMA Neurol,2018,75(2):203-211.

[2] 诸骏仁,高润霖,赵水平,等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华健康管理学杂志,2017,11(1):7-28.

[3] Touboul PJ,Hennerici MG,Meairs S,et al. Mannheim carotid intima-media thickness and plaque consensus(2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia,at the 13th,15th and 20th European Stroke Conferences,Mannheim,Germany,2004,Brussels,Belgium,2006,and Hamburg,Germany,2011[J]. Cerebrovasc Dis,2012,34(4):290-296.

[4] Franceschini N,Giambartolomei C,de Vries PS,et al. GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes[J]. Nat Commun,2018,9(1):5141.

[5] Hollander M,Bots ML,Del Sol AI,et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly:the Rotterdam study[J]. Circulation,2002,105(24):2872-2877.

[6] Nam HS,Han SW,Lee JY,et al. Association of aortic plaque with intracranial atherosclerosis in patients with stroke[J]. Neurology,2006,67(7):1184-1188.

[7] Gongora-Rivera F,Labreuche J,Jaramillo A,et al. Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke[J]. Stroke,2007,38(4):1203-1210.

[8] Steg PG,Bhatt DL,Wilson PW,et al. One-year cardiovascular event rates in outpatients with atherothrombosis[J]. JAMA,2007,297(11):1197-1206.

[9] Zhao X,Hippe DS,Li R,et al. Prevalence and characteristics of carotid artery high-risk atherosclerotic plaques in Chinese patients with cerebrovascular symptoms:a Chinese Atherosclerosis Risk Evaluation Ⅱ study[J]. J Am Heart Assoc,2017,6(8):e005831.

[10] Olejarz W,?acheta D,Kubiak-Tomaszewska G. Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability[J]. Int J Mol Sci,2020,21(11):3946.

[11] Schindler A,Schinner R,Altaf N,et al. Prediction of stroke risk by detection of hemorrhage in carotid plaques:meta-analysis of individual patient data[J]. JACC Cardiovasc Imaging,2020,13(2 pt 1):395-406.

[12] Polak JF,Shemanski L,O’Leary DH,et al. Hypoechoic plaque at US of the carotid artery:an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study[J]. Radiology,1998,208(3):649-654.

[13] Kashiwazaki D,Yamamoto S,Akioka N,et al. Inflammation coupling between unstable carotid plaque and spleen-A 18F-fluorodeoxyglucos positron emission tomography study[J]. J Stroke Cerebrovasc Dis,2018,27(11):3212-3217.

[14] Kelly PJ,Camps-Renom P,Giannotti N,et al. A risk score including carotid plaque inflammation and stenosis severity improves identification of recurrent stroke[J]. Stroke,2020,51(3):838-845.

[15] Tabas I,García-Carde?a G,Owens GK. Recent insights into the cellular biology of atherosclerosis[J]. J Cell Biol,2015,209(1):13-22.

[16] Chistiakov DA,Melnichenko AA,Grechko AV,et al. Potential of anti-inflammatory agents for treatment of atherosclerosis[J]. Exp Mol Pathol,2018,104(2):114-124.

[17] Held C,White HD,Stewart RAH,et al. Inflammatory biomarkers interleukin-6 and C-reactive protein and outcomes in stable coronary heart disease:experiences from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial[J]. J Am Heart Assoc,2017,6(10):e005077.

[18] Madan M,Bishayi B,Hoge M,et al. Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model[J]. Atherosclerosis,2008,197(2):504-514.

[19] Tesauro M,Mauriello A,Rovella V,et al. Arterial ageing:from endothelial dysfunction to vascular calcification[J]. J Intern Med,2017,281(5):471-482.

[20] Yang EY,Chambless L,Sharrett AR,et al. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities(ARIC) study[J]. Stroke,2012,43(1):103-108.

[21] Yang J,Pan X,Zhang B,et al. Superficial and multiple calcifications and ulceration associate with intraplaque hemorrhage in the carotid atherosclerotic plaque[J]. Eur Radiol,2018,28(12):4968-4977.

[22] Ding J,Mitchell GF,Bots ML,et al. Carotid arterial stiffness and risk of incident cerebral microbleeds in older people:the Age,Gene/Environment Susceptibility(AGES)-Reykjavik study[J]. Arterioscler Thromb Vasc Biol,2015,35(8):1889-1895.

[23] Beaussier H,Masson I,Collin C,et al. Carotid plaque,arterial stiffness gradient,and remodeling in hypertension[J]. Hypertension,2008,52(4):729-736.

[24] 刘欢,王宏宇,刘金波,等. 颈动脉斑块患者大动脉功能与冠心病和下肢动脉疾病的关系[J]. 北京大学学报(医学版),2017,49(6):1027-1033.

[25] 刘欢,何映东,刘金波,等. 血管健康指标对新发心脑血管事件的预测价值:北京血管健康分级标准的初步验证[J]. 北京大学学报(医学版),2020,52(3):514-520.

[26] Liu H,Liu J,Huang W,et al. Association between multi-site atherosclerotic plaques and systemic arteriosclerosis:results from the BEST study(Beijing Vascular Disease Patients Evaluation Study)[J]. Cardiovasc Ultrasound,2020,18(1):30.

[27] Liu H,Xie W,Liu J,et al. Comparison of vascular-related diseases in their associations with carotid femoral pulse wave velocity:from the Beijing Vascular Disease Patients Evaluation Study(BEST Study)[J]. Int J Clin Pract,2019,73(11):e13400.

相似文献/References:

[1]李乐亮,综述,李萍,等.炎症标志物与颈动脉粥样斑块的稳定性[J].心血管病学进展,2016,(3):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
 LI Leliang,LI Ping.Stability of Inflammatory Markers and Carotid Artery Plaque[J].Advances in Cardiovascular Diseases,2016,(3):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
[2]耿春晖 关秀茹.MicroRNA作为动脉粥样硬化的诊断生物标志物的研究进展[J].心血管病学进展,2019,(7):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
 GENG Chunhui,GUAN Xiuru.microRNA as a Diagnostic Biomarker for Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(3):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
[3]乐健 何胜虎.前蛋白转化酶枯草溶菌素9致动脉粥样硬化的机制研究进展[J].心血管病学进展,2019,(7):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
 YUE Jian,HE Shenghu.Advances in the mechanism of PCSK9-induced atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(3):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
[4]武亚琳,梁斌,杨志明.NLRP3/IL-1β途径的促动脉粥样硬化作用及临床应用[J].心血管病学进展,2019,(6):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
 WU Yalin,LIANG Bin,YANG Zhiming.The Role of NLRP3/IL-1in Atherosclerosis and Clinical Application[J].Advances in Cardiovascular Diseases,2019,(3):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
[5]李琦玉 ?张宁 陈婧 黄浙勇.动脉粥样硬化的抗血小板分子靶向治疗[J].心血管病学进展,2019,(5):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
 LI Qiyu,ZHANG Ning,CHEN Jing,et al.Anti-Platelet Molecular Targeted Therapy or Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(3):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
[6]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
 HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(3):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[7]焦新峰 刘正霞 鲁翔.白介素-8在冠心病中的研究进展[J].心血管病学进展,2019,(8):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
 JIAO Xinfeng,LIU Zhengxia,LU Xiang.Research Progress of Interleukin-8 in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(3):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
[8]徐侨 刘正霞 鲁翔.白介素22在动脉粥样硬化和2型糖尿病中的作用[J].心血管病学进展,2019,(9):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
 XU Qiao,LIU Zhengxia,LU Xiang.IL-22 in Atherosclerosis and Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(3):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
[9]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
 SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(3):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[10]代承忠 彭礼清 余建群 刘静 蒲华霞.双源CT血管成像评价经导管主动脉瓣置入术术前患者颈动脉斑块[J].心血管病学进展,2019,(8):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]
 DAI Chengzhong,PENG Liqing,YU Jianqun,et al.Evaluation of Carotid Arteries Plaques in Patients Referred for TAVI with Dual-source CT Angiography[J].Advances in Cardiovascular Diseases,2019,(3):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]

更新日期/Last Update: 2021-05-27